相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
Hui-Fu Wang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Pharmacological Treatment of Parkinson Disease A Review
Barbara S. Connolly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia
Paul Edison et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Oral Anticoagulation Therapy in Heart Failure Patients in Sinus Rhythm: A Systematic Review and Meta-Analysis
Giuseppe Rengo et al.
PLOS ONE (2013)
Clinical Trials of Dementia With Lewy Bodies and Parkinson's Disease Dementia
D. Aarsland et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)
Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study
Bruno Dubois et al.
MOVEMENT DISORDERS (2012)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
Klaus Seppi et al.
MOVEMENT DISORDERS (2011)
Health-related quality of life and its determinants in Parkinson's disease: Results of an Italian cohort study
Yaroslav Winter et al.
PARKINSONISM & RELATED DISORDERS (2011)
The basal nucleus of Meynert in idiopathic Parkinson's disease
F. Tagliavini et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Ageing, neurodegeneration and Parkinson's disease
John V. Hindle
AGE AND AGEING (2010)
Cognition and the Risk of Hospitalization for Serious Falls in the Elderly: Results From the Cardiovascular Health Study
Diana B. Welmerink et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2010)
Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease
Kathryn A. Chung et al.
NEUROLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia - A retrospective analysis of a double-blind trial and an open-label extension
Wolfgang Oertel et al.
DRUG SAFETY (2008)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
Differences in neuropathologic characteristics across the Lewy body dementia spectrum
C. Ballard et al.
NEUROLOGY (2006)
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance
Paolo Calabresi et al.
LANCET NEUROLOGY (2006)
Non-motor symptoms of Parkinson's disease: diagnosis and management
KR Chaudhuri et al.
LANCET NEUROLOGY (2006)
Dementia in Parkinson disease - Functional imaging of cholinergic and dopaminergic pathways
R Hilker et al.
NEUROLOGY (2005)
Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study
B Ravina et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Prevalence of gait disorders in hospitalized neurological patients
H Stolze et al.
MOVEMENT DISORDERS (2005)
Rivastigmine for dementia associated with Parkinson's disease
M Emre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study
DJ Burn et al.
MOVEMENT DISORDERS (2003)
Systematic reviews in health care - Investigating and dealing with publication and other biases in meta-analysis
JAC Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
分享论文
